Researchers have discovered that combining immunotherapy and chemotherapy can overcome treatment resistance in a subset of ...

Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic ...

Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor genes were more ...

Individuals can make various changes to their lifestyles to help reduce their chances of developing certain types of cancer, ...

A study shows that combining dual immunotherapy with chemotherapy improves outcomes for metastatic non-squamous NSCLC patients with STK11 and KEAP1 mutations. Learn more ...

Study finds patients with advanced non-small cell lung cancer and STK11 and/or KEAP1 mutations had improved outcomes with combination treatment Study results, published today in Nature ...

harboring specific mutations in the STK11 ... Common Breast Cancer Treatments May Speed Aging Process Oct. 7, 2024 — Markers of cellular aging -- such as DNA damage response, cellular senescence ...

Alterations in the tumour suppressor genes STK11 and/or KEAP1 can identify patients with advanced non-small-cell lung cancer who are likely to benefit from combinations of PD-(L)1 and CTLA4 immune ...

harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor genes were more likely to benefit from adding the immunotherapy tremelimumab to a combination of durvalumab plus ...

In the 1990s, China began sending pandas to foreign zoos to be bred, in the hope that future generations could be released into the wild. It hasn’t gone as planned. By Mara Hvistendahl and Joy ...